- Home
- DTE vs BNTX Comparison
DTE vs BNTX Comparison
Compare DTE & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DTE | BNTX |
|---|---|---|
| Founded | 1903 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.3B | 24.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | DTE | BNTX |
|---|---|---|
| Price | $128.97 | $95.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 11 |
| Target Price | ★ $149.09 | $137.40 |
| AVG Volume (30 Days) | ★ 1.7M | 1.4M |
| Earning Date | 02-12-2026 | 11-03-2025 |
| Dividend Yield | ★ 3.61% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.67 | N/A |
| Revenue | ★ $14,822,000,000.00 | $3,698,814,972.00 |
| Revenue This Year | $11.59 | $2.03 |
| Revenue Next Year | $4.75 | N/A |
| P/E Ratio | $19.34 | ★ N/A |
| Revenue Growth | ★ 19.39 | 3.70 |
| 52 Week Low | $116.30 | $81.20 |
| 52 Week High | $143.79 | $129.27 |
Technical Indicators
Market Signals| Indicator | DTE | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 39.15 | 45.84 |
| Support Level | $126.23 | $94.00 |
| Resistance Level | $130.29 | $95.71 |
| Average True Range (ATR) | 1.46 | 1.74 |
| MACD | 0.30 | 0.52 |
| Stochastic Oscillator | 46.60 | 62.66 |
Price Performance
Historical ComparisonAbout DTE DTE Energy Company
DTE Energy owns two regulated utilities in Michigan that contribute 90% of earnings. DTE Electric serves approximately 2.3 million customers in southeastern Michigan, including Detroit. DTE Gas serves 1.3 million customers throughout the state. In addition, DTE has nonutility businesses and investments including energy marketing and trading, renewable natural gas facilities, and on-site industrial energy projects.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.